17.60
Seaport Therapeutics Inc Azioni (SPTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 |
| Durata del periodo | 3 mesi | 3 mesi |
| Operating Expenses |
138.93%
65.81
|
27.54 |
| Operating Income/Loss |
138.93%
-65.81
|
-27.54 |
| Nonoperating Income/Loss |
30.33%
3.459
|
2.654 |
| Income/Loss From Continuing Operations Before Tax |
150.51%
-62.35
|
-24.89 |
| Income Tax Expense/Benefit |
51.64%
0.251
|
0.519 |
| Net Income/Loss |
146.38%
-62.60
|
-25.41 |
| Basic Average Shares |
1,334%
35.24
|
2.4568 |
| Diluted Average Shares |
1,334%
35.24
|
2.4568 |
| Basic Earnings Per Share |
82.79%
-1.78
|
-10.34 |
| Diluted Earnings Per Share |
82.79%
-1.78
|
-10.34 |
| Common Stock Dividends |
-
|
- |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):